vaccinia-tyrosinase vaccine

BIOLOGICAL2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Melanoma (Skin)

Phase 2

Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

CompletedNCT00054535

National Cancer Institute (NCI)Melanoma (Skin)

Start: 2003-01-31End: 2004-09-30Updated: 2013-06-19

Vaccine Therapy in Treating Patients With Metastatic Melanoma

CompletedNCT00019734

National Cancer Institute (NCI)Melanoma (Skin)

Start: 1999-07-31End: 2003-05-31Updated: 2013-06-20